The Problem of Prenatal Cocaine Exposure: A Rush to Judgment

JAMA: The Journal of the American Medical Association

Volumn 267, Issue 3, 1992, Pages 406-408

  Mayes, Linda C ^a   Granger, Richard H ^a   Bornstein, Marc H ^b   Zuckerman, Barry ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE;

FETUS; HUMAN; NOTE; POLITICS; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; SOCIAL ASPECT;

CLINICAL APPROACH/SOURCE; DISADVANTAGED; DRUG ABUSE; GENETICS AND REPRODUCTION; INFANTS; OBLIGATIONS OF SOCIETY; PREGNANT WOMEN; PRENATAL INJURIES; STIGMATIZATION;

ATTITUDE TO HEALTH; BRAIN DISEASES; CHILD; COCAINE; FEMALE; HUMANS; INFANT, NEWBORN; MATERNAL-FETAL EXCHANGE; POLITICS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANT WOMEN; SOCIAL JUSTICE; SOCIOLOGY; SUBSTANCE-RELATED DISORDERS; VULNERABLE POPULATIONS;

EID: 84944965390     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1992.03480030084043     Document Type: Article

References (43)

1. National Institute on Drug Abuse. National Household Survey on Drug Abuse for 1990. Bethesda, Md: National Institute on Drug Abuse; 1991.
2. Chasnoff I. Drug use in pregnancy: parameters of risk. Pediatr Clin North Am. 1988;35:1403-1412.
3. National Institute of Justice. Drug Use Forecasting. Washington, DC: National Institute of Justice; April 1990.
4. Chasnoff IJ, Landress H, Barett M. The prevalence of illicit-drug or alcohol use during pregnancy and discrepancies in mandatory reporting in Pinellas County, Florida. N Engl J Med. 1990;322:1202-1206.
5. Osterloh JD, Lee BL. Urine drug screening in mothers and newborns. AJDC. 1989;143:791-793.
6. Zuckerman B, Frank DA, Hingson R, et al. Effects of maternal marijuana and cocaine use on fetal growth. N Engl J Med. 1989;320:762-768.
7. Lester BM, Corwin MJ, Sepkoski C, et al. Neurobehavioral syndromes in cocaine exposed newborn infants. Child Dev. 1991;62:694-705.
8. Chasnoff IJ, Burns KA, Burns WJ. Cocaine use in pregnancy: perinatal morbidity and mortality. Neurobehav Toxicol Teratol. 1987;9:291-293.
9. Neerhof MG, MacGregor SN, Retsky SS, Sullivan TP. Cocaine abuse during pregnancy: peripartum prevalence and perinatal outcome. Am J Obstet Gynecol. 1989;161:633-638.
10. Hadeed AJ, Siegel SR. Maternal cocaine use during pregnancy: effect on the newborn infant. Pediatrics. 1989;84:205-210.
11. Little BB, Snell LM, Klein VR, Gilstrap LC. Cocaine abuse during pregnancy: maternal and fetal implications. J Obstet Gynecol. 1989;73:157-160.
12. Zuckerman B, Bresnahan K. Developmental and behavioral consequences of prenatal drug and alcohol exposure. Pediatr Clin North Am. 1991;38:1-19.
13. Zuckerman B, Frank DA. Marijuana and cocaine: clinical implications. In: Zagon I, Slotkin T, eds. Maternal Substance Abuse and Neural Development. In press.
14. Doberczak TM, Shanzery S, Senie RT, Kandall SR. Neonatal neurologic and electroencephalographic effects of intrauterine cocaine exposure. J Pediatr. 1988;113:354-358.
15. Isenberg SJ, Spierer A, Inkelis SH. Ocular signs of cocaine intoxication in neonates. Am J Ophthalmol. 1987;103:211-214.
16. Salamy A, Eldredge L, Anderson J, Bull D. Brain-stem transmission time in infants exposed to cocaine in utero. J Pediatr. 1990;117:627-629.
17. Shih L, Cone-Wesson B, Reddix B. Effects of maternal cocaine abuse on the neonatal auditory system. Int J Pediatr Otorhinolaryngol. 1988;15:245-251.
18. Teske MP, Trese MT. Retinopathy of prematurity-like fundus and persistent hyperplastic primary vitreous associated with maternal cocaine use. Am J Ophthalmol. 1987;103:719-720.
19. Chasnoff IJ, Burns KA, Burns WJ, Scholl SH. Prenatal drug exposure: effects on neonatal growth and development. Neurobehav Toxicol Teratol. 1986;8:357-362.
20. Chasnoff IJ, Hunt CE, Kletter R, Kaplan D. Prenatal cocaine exposure is associated with respiratory pattern abnormalities. AJDC. 1989;143:583-587.
21. Bauchner H, Zuckerman B, McClain M, Frank D, Fried D, Kayne H. Risk of sudden infant death syndrome among infants with in utero exposure to cocaine. J Pediatr. 1988;113:831-834.
22. Davidson SL, Bautista D, Chan L, et al. Sudden infant death syndrome in infants of substance-abusing mothers. J Pediatr. 1990;117:876-881.
23. Durand DJ, Espinoza AM, Nickerson BG. Association between prenatal cocaine exposure and sudden infant death syndrome. J Pediatr. 1990;117:909-911.
24. Bauchner H, Zuckerman B. Cocaine, SIDS and home monitoring. J Pediatr. 1990;117:904-906.
25. Kandall SR, Gaines J. Maternal substance use and subsequent sudden infant death syndrome (SIDS) in offspring. Neurotoxicol Teratol. 1991;13:235-240.
26. Zuckerman B, Amaro H, Cabral H. Validity of self-reporting of marijuana and cocaine use among pregnant adolescents. J Pediatr. 1989;115:812-815.
27. Zuckerman B. Selected methodological issues in investigations of prenatal effects of cocaine: lessons from the past. NIDA Res Monogr. In press.
28. Bornstein MH. Sensitive periods in development: structural characteristics and causal interpretations. Psychol Bull. 1989;105:179-197.
29. Frank DA, Zuckerman BS, Amaro H, et al. Cocaine use during pregnancy: prevalence and correlates. Pediatrics. 1988;82:888-895.
30. Chasnoff IJ, Griffith DR, MacGregor S, Dirkes K, Burns KA. Temporal patterns of cocaine use in pregnancy: perinatal outcome. JAMA. 1989;261:1741-1744.
31. Regan DO, Leifer B, Finnegan LP. Depression, self-concept, and violent experience in drug abusing women and their influence upon parenting effectiveness. NIDA Res Monogr. 1984;49:332.
32. Bornstein MH. Between caretakers and their young: two modes of interaction and their consequences for cognitive growth. In: Bornstein MH, Bruner JS, eds. Interaction in Human Development. Hillsdale, NJ: Lawrence Erlbaum Associates; 1989:237-294.
33. Jacobs BL. Overview of the activity of the brain monoaminergic neurons across the sleep-wake cycle. In: Wauquier A, Monti JM, Radilovacki M, eds. Sleep-Neurotransmitters and Neuromodulators. New York, NY: Raven Press; 1985:1-14.
34. Dixon SD, Bejar R. Echoencephalographic findings in neonates associated with maternal cocaine and methamphetamine use: incidence and clinical correlates. J Pediatr. 1989;115:770-778.
35. Rosenthal R, Jacobson L. Pygmalion in the Classroom: Teacher Expectation and Pupils’ Intellectual Development. New York, NY: Holt Rinehart & Winston; 1968.
36. Koren G, Graham K, Shear H, Einarson T. Bias against the null hypothesis: the reproductive hazards of cocaine. Lancet. 1989;2:1440-1442.
37. Meisels SJ, Shonkoff JP. Handbook of Early Childhood Intervention. New York, NY: Cambridge University Press; 1990.
38. Beckwith L, Parmelee AH Jr. EEG patterns of preterm infants, home environment and later IQ. Child Dev. 1986;57:777-789.
39. Werner E. Children of the Garden Island. Sci Am. April 1989:106-111.
40. Infant Health and Development Program. Enhancing the outcomes of low-birthweight, premature infants: a multisite, randomized trial. JAMA. 1990;263:3035-3042.
41. Sameroff AJ. Developmental systems: contexts and evolution. In: Kessen W, Mussen PH, eds. Handbook of Child Psychology, 1: History, Theory and Methods. New York, NY: John Wiley & Sons Inc; 1983:237-294.
42. Lifshitz M, Wilson GS, Smith E, Desmond M. Factors affecting head growth and intellectual function in children of drug addicts. Pediatrics. 1985;75:269-274.
43. Zuckerman B. Testimony before the US House of Representatives, Committee on Ways and Means, Subcommittee on Human Resources. April 3, 1990.